S. Ott (Bern, Switzerland), H. Popper (Graz, Austria), T. Berghmans (Brussels, Belgium), G. Hardavella (Athens, Greece)
Tumor laterality influences the prognostic impact of Bcl-2 expression in curatively resected NSCLC patients
L. H. Schmidt, T. Spieker, M. Schuler, A. Marra, K. Wiebe, W. Berdel, C. Mueller-Tidow, W. Rainer (Münster, Essen, Ostercappeln, Germany)
|  |
beta-F1-ATPase expression as a prognostic factor for resected non-small cell lung cancer
R. Alonso Moralejo, A. Hernandez Voth, R. Garcia Lujan, C. Alvarez Martinez, A. Lopez Encuentra (Madrid, Spain)
| |
Hyaluronidase, hyaluronan synthase, E-cadherin and TGF-beta profile in lung adenocarcinoma subtypes and squamous cell carcinoma of smokers/nonsmokers
V. de Sá, L. Carvalho, A. Alarcão, A. Gomes, P. Couceiro, F. Soares, V. Capelozzi (São Paulo, Coimbra, Brazil)
|  |
Prognostic value study of lung cancer molecular markers and value of mitochondrial activity in resected non-small cell lung cancer
R. Alonso Moralejo, J. Pinillos Robles, R. Garcia Lujan, C. Alvarez Martinez, A. Lopez Encuentra (Madrid, Spain)
| |
The prognostic significance of metastasis to aortopulmonary lymph nodes in completely resected left lung tumors
N. Citak, A. Sayar, M. Metin, S. Büyükkale, A. Kök, A. çelikten, O. Solak, S. Yurt, N. A. Fener, A. Gürses (Kars, Istanbul, Afyon, Turkey)
| |
Prognostic significance of serum vascular endothelial growth factor and angiopoietin-2 in lung cancer
P. Akin Kabalak, A. çiledag, G. çelik, N. Demir, C. Yüksel, G. Köycü, D. Gökmen Öztuna, A. Taner, A. Kaya, H. Kutlay, I. Savas, N. Numanoglu (Ankara, Turkey)
| |
The protein DJ-1 in malignant pleural effusions due to lung cancer: Levels and correlations with oxidative stress biomarkers
G. Vavougios, T. Kerenidi, I. Tsilioni, K. Gourgoulianis (Larissa, Greece)
| |
Evaluation of IL-10 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
M. Petrovic, I. Cekerevac, G. Kostic, G. Davidovic, V. Iric-Cupic (Kragujevac, Republic Of Serbia)
| |
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients
M. Petrovic, I. Cekerevac, Z. Lazic, V. Zdravkovic (Kragujevac, Republic Of Serbia)
| |
Does IASLC/ATS/ERS classification of lung adenocarcinoma impacts prognosis?
I. Neves, S. Guimaraes, C. Souto Moura, F. S. Pires, A. P. Vaz, P. Bastos, H. Queiroga, V. Hespanhol, G. Fernandes (Porto, Portugal)
| |
The prognostic value of D-dimer in lung carcinoma
C. Anar, T. Inal, I. Ünsal, H. Halilçolar, G. Polat, S. Anar (Izmir, Turkey)
| |
Epidermal growth factor receptor and related biomarkers evaluated by immunohistochemistry in patients with resected non-small cell lung cancer
L. Antonangelo, B. Silva, T. Tuma, L. Marcal, M. Acencio, E. Parra, R. Terra, F. Vargas, V. Capelozzi (Sao Paulo, Brazil)
| |
Prognostic factors affecting survival in cases with lung cancer [A lung cancer mapping project in Turkey (LCMPT)]
T. Goksel, S. Eser, S. Z. Guclu, M. Karadag, A. Cilli, T. Ozlu, M. Gorguner, U. Gonlugur, F. Topcu, Turkish Lung Cancer Mapping Project Study Group (Ankara, Turkey)
| |
Long-term survival is linked to serum LDH normalization in SCLC
C. Chen, J. Huang (Suzhou, China)
| |
Prognostic factors for survival in lung cancer
S. Souilah, F. Z. El Allia, M. Kacimi, A. Fissah, S. Taright, R. Amrane (Algiers, Algeria)
| |
A detailed immunohistochemical analysis of PI3K/AKT/MTOR pathway in lung cancer: Correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features
E. Trigka, G. Hardavella, A. Saetta, N. Kavantzas, P. Korkolopoulou, N. Anastasiou, E. Patsouris (Athens, Greece)
| |
Subtyping agreement between small cyto-histological samples and surgical specimens in NSCLC patients
I. Neves, F. S. Pires, A. P. Vaz, C. Souto Moura, P. Bastos, H. Queiroga, V. Hespanhol, G. Fernandes (Porto, Portugal)
| |
mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation
R. F. H. Walter, F. D. Mairinger, R. Werner, S. Ting, T. Hager, C. Vollbrecht, D. Christoph, K. W. Schmid, J. Wohlschlaeger (Essen, Koeln, Germany)
| |
Frequency and type of EGFR mutations in patients with adenocarcinoma of the lung
N. Blanco Cid, I. Parente Lamelas, J. Abal Arca, H. Gómez Márquez, P. Marcos Velázquez (Ourense, Spain)
| |